Abstract: Bile acids are abundantly present in the mammalian gut, where they undergo bacteriamediated transformation, generating a large pool of bioactive molecules. While they have been shown to affect host metabolism, cancer progression and innate immunity, it is unknown whether bile acids affect the function of adaptive immune cells such as T cells expressing IL-17a (Th17
Main Text:
Bile acids are cholesterol-derived natural surfactants, produced in the liver and secreted into the duodenum. They are critical for lipid digestion, antibacterial defense and glucose metabolism 1 . While 95% of bile acids are re-absorbed through the terminal ileum of the small intestine and recirculated to the liver, hundreds of milligrams of bile acids are subject to bacterial-mediated transformation and become secondary bile acids with unique chemical 5 structures and biological activities 2, 3 . In the healthy human gut, the concentrations of secondary bile acids are in the hundreds of micromolar range 2, 4 . While some bile acids disrupt cellular membranes due to their hydrophobic nature 5 , other bile acids protect the gut epithelium 6 and confer resistance to infection with invasive pathogens such as Clostridium difficile 7 . In addition, bile acids were shown to influence gut-associated inflammation, suggesting their potential to 10 regulate gut mucosal immune cells 8, 9 . The immune-modulatory effects of bile acids have mostly been studied in the context of innate immunity [10] [11] [12] . Although a recent study reported the cytotoxic effects of bile acids on gut-residing T cells 13 , whether they modulate T cell function directly has not been thoroughly examined. Since the identification of digoxin, a plant-derived small molecule harboring a sterol-like core, as the first Th17 cell-specific inhibitor that directly 15 binds to RORγt and inhibits its activity 14 , other structurally similar cholesterol derivatives have been identified as RORγt modulators [15] [16] [17] . Because bile acids belong to a family of cholesterol metabolites and predominantly exist in the gut where many Th17 cells are present 18 , we reasoned that bile acids might be involved in controlling the function of Th17 cells by modulating RORγt
activity. 20
To identify bile acids with modulatory effects on T cell differentiation, we screened ~30 compounds. We included both primary bile acids, which are synthesized by the host, and secondary bile acids, which are produced by bacterial modification of primary bile acids, in our screen. Naïve CD4 + T cells were isolated from wild-type C57BL/6J (B6) mice and cultured with the bile acids under Th17 and, as a counter-screen, Treg differentiation conditions (Extended Data Fig. 1a-c) . Strikingly, two distinct derivatives of LCA were found to significantly affect Th17 and Treg cell differentiation. While 3-oxoLCA inhibited Th17 differentiation, isoalloLCA enhanced Tregs, as shown by reduced IL-17a with the former and increased Foxp3 expression 5 with the latter (Fig. 1a, b and Extended Data Fig. 1c ). The Treg-enhancing effect of isoalloLCA was particularly evident when T cells were cultured with low levels of TGF-β ( and isoalloLCA on Tregs were cell-type specific, as neither compound affected T cell differentiation into Th1 or Th2 cells (Fig. 1a, b) . While 3-oxoLCA did not affect Treg cell differentiation ( Fig. 1b and Extended Data Fig. 1b) , isoalloLCA treatment led to ~40-50% reduction of Th17 cell differentiation (Fig. 1a, b) . Importantly, both compounds exhibited their T 15 cell modulatory effects in a dose-dependent manner (Fig. 1c) . While 3-oxoLCA did not affect cell proliferation, isoalloLCA addition to T cells led to reduced proliferation compared to treatment with DMSO (Extended Data Fig. 2f ). IsoalloLCA treatment impaired neither cell viability (Extended Data Fig. 2g ) nor T cell receptor (TCR)-mediated activation, as indicated by similar expression levels of TCR activation markers such as CD25, CD69, Nur77 and CD44 20 (Extended Data Fig. 3a ). Treg-enhancement by isoalloLCA required strong TCR activation, as increasing TCR activation with higher concentrations of anti-CD3 resulted in stronger effects on Foxp3 expression without affecting cell viability (Extended Data Fig. 3b-d) .
To elucidate the mechanisms by which 3-oxoLCA inhibits Th17 cell differentiation, we T cells were gated for analyses on day 3 for Th17 and Treg, day 5 for Th1 and Th2. c, 3-oxoLCA and isoalloLCA demonstrate dose-dependent effects on Th17 cell and Treg differentiation, respectively. Error bars represent standard deviation. ns; not-significant, ****; p<0.0001, ***; p<0.001 by unpaired t-test with 2-tailed p-value. 3-oxoLCA exhibited a robust physical interaction with the RORγt LBD at the equilibrium dissociation constant (Kd) of ~1 µM. We also tested two other structurally similar 3-oxo derivatives of bile acids, 3-oxocholic acid (3-oxoCA) and 3-oxodeoxycholic acid (3-5 oxoDCA) (Fig. 2a) , and demonstrated that these derivatives had ~20 times higher Kd values than 3-oxoLCA (Fig. 2b) . In line with this observation, neither 3-oxoCA nor 3-oxoDCA inhibited Th17 cell differentiation as robustly as 3-oxoLCA (Fig. 2c, d ). These results suggest that addition of a 3-oxo moiety does not alone confer RORγt-binding activity to bile acids. Next, we examined if 3-oxoLCA can modulate the transcriptional activity of RORγt. As a surrogate 10 reporter for RORγt transcriptional activity, we assayed the effect of the bile acids on firefly luciferase expression directed by a fusion protein of RORγt and Gal4-DBD (DNA binding domain) in human embryonic kidney (HEK) 293 cells. Unlike cells treated with DMSO, cells treated with ML209, a specific RORγt antagonist, completely lost RORγt activity 19 . Likewise, 3-oxoLCA treatment significantly reduced the RORγt reporter activity (Fig. 2e) . Altogether, these 15 data suggest that 3-oxoLCA likely inhibits Th17 cell differentiation by physically interacting with RORγt and disabling its transcriptional activity. 3-oxoLCA binds to RORγ LBD at much lower Kd value than the other two structurally similar bile acids. c and d, Flow cytometric analyses and quantification of the production of IL-17a from mouse naïve CD4 + T cells cultured for 3 days under Th17 polarization condition. DMSO or bile acids at 20 µM were added 18 h after cytokine addition. e, 3-oxoLCA, but not 3-oxoCA and 3-oxoDCA, selectively inhibits RORγ-dependent transcriptional activity. Ratio of firefly to Renilla luciferase activity is presented on the y-axis. Error bars represent standard deviation. ns; notsignificant, ****; p<0.0001, ***; p<0.001, **; p<0.01, *; p<0.01 by upaired t-test with 2-tailed p-value, compared to DMSO control.
We next sought to uncover the mechanism by which isoalloLCA exerts its enhancing effects on Tregs. First, we examined whether other metabolites of LCA can induce Treg cell differentiation. LCA has a 3α-hydroxyl group as well as a cis 5β-hydrogen configuration at the A/B ring junction. This molecule can undergo isomerization, presumably via the actions of gut bacterial enzymes 2 , to form isoLCA (3β,5β), alloLCA (3α,5α) or isoalloLCA (3β,5α) (Fig. 3a) . 5
IsoalloLCA, but not the other LCA isomers nor 3-oxoLCA, enhanced Foxp3 expression, confirming that both the 3β-hydroxyl group and trans (5α-hydrogen) A/B ring configuration of isoalloLCA are required for Treg enhancement (Fig. 3b) . Compared to DMSO-treated cells, isoalloLCA-treated cells significantly inhibited T effector cell proliferation in vitro, indicating that they had acquired regulatory activity (Fig. 3c, d ). We next investigated whether isoalloLCA 10 enhances Foxp3 expression transcriptionally or post-transcriptionally. T cells isolated from Foxp3-GFP reporter mice exhibited both increased foxp3 mRNA expression (Fig. 3e ) and enhanced GFP levels upon treatment with isoalloLCA (Extended Data Fig. 4a ). Thus, isoalloLCA-induced enhanced expression of Foxp3 occurs at the foxp3 mRNA transcriptional level. 15
The transcriptional regulation of Foxp3 is governed by three conserved non-coding enhancers, termed CNS1, 2 and 3 (Fig. 3f) . These enhancer regions have distinct roles in regulating Treg development, stability and function [20] [21] [22] . Fig. 5b and d) . isoLCA (3b,5b) alloLCA (3a,5a) isoalloLCA (3b,5a) Figure 3A . decreased ECAR, both in WT and CNS3-KO cells (Fig. 3h, i) . Notably, isoalloLCA-treated cells were not responsive to oligomycin treatment, which may suggest modified mitochondrial function. Indeed, isoalloLCA-treated cells were found with reduced numbers of fused mitochondria (Fig. 3j, k) , which may reflect changes in metabolic activities in mitochondria 38 .
Taken together, these findings suggest that isoalloLCA treatment may lead to increased 20 mitochondrial activity. Reactive oxygen species (ROS) are produced as byproducts of mitochondrial OxPhos. Whereas D-mannose was previously shown to increase cytoplasmic ROS production 37 , isoalloLCA treatment led to increased production of mitochondrial ROS (mtROS), without affecting cytoplasmic ROS ( Fig. 3l and Extended Data Fig. 6h ). Unlike isoalloLCA, other LCA isomers failed to increase mtROS production (Fig. 3l) . On the other hand, consistent with the increased mitochondrial respiration, isoalloLCA-treated cells displayed a modest, but significant, increase in mitochondrial membrane potential (Extended Data Fig. 6i ). To test if mtROS is directly involved in enhanced Treg differentiation by isoalloLCA, we employed 5 mitoQ, a mitochondrially-targeted antioxidant, to reduce ROS levels in mitochondria (Fig. 3m) .
Importantly, in the presence of mitoQ, isoalloLCA was no longer effective in enhancing Treg cell differentiation (Fig. 3n) . In contrast, RA-dependent induction of Tregs was unaffected by mitoQ treatment (Fig. 3n) , thus suggesting distinct modes of action of isoalloLCA and RA. We next investigated if mtROS production is also responsible for the enhanced H3K27Ac levels at 10 the Foxp3 promoter of isoalloLCA-treated cells. Co-treating cells with isoalloLCA and mitoQ led to decreased H3K27Ac levels, compared to those treated with isoalloLCA only (Extended Data Fig. 6j ). Therefore, increased mtROS levels likely contribute to isoalloLCA-dependent Treg enhancement. Recently, Foxp3 itself has been shown to enhance mitochondrial OxPhos 39 . In line with this finding, Foxp3-expressing Tregs were found with higher mtROS levels compared to 15 other in vitro differentiated CD4 + T cell subsets (Extended Data Fig. 6k ). Thus, we investigated if increased mtROS production observed in isoalloLCA-treated cells was a secondary effect of enhanced Foxp3 expression. CNS3-deficient cells that did not express high levels of Foxp3 in response to isoalloLCA treatment nevertheless produced increased levels of mtROS as well as enhanced OxPhos (Fig. 3h and o) . Taken together, our data thus support a model in which 20 isoalloLCA enhances mtROS production, due to elevated mitochondrial metabolism, which leads to the increased acetylation of H3K27 at the Foxp3 promoter region and enhanced Foxp3 mRNA transcription (Extended Data Fig. 6l ). We next examined whether 3-oxoLCA and isoalloLCA could influence Th17 and Treg cell differentiation in vivo using a mouse model. Segmented filamentous bacteria (SFB), a murine commensal, is known to induce Th17 cell differentiation in the small intestine of B6 mice upon colonization 40 . C57BL/6NTac mice from Taconic Biosciences (Tac) have abundant Th17 cells in their small intestine owing to the presence of SFB. In contrast, C57BL/6J mice from Jackson Laboratories (Jax), which lack SFB, have few intestinal Th17 cells. To first test the in vivo effects of 3-oxoLCA in suppressing Th17 cells, we gavaged Jax-B6 mice with an SFB-5 containing fecal slurry and fed them either a control diet or 0.3% (w/w) 3-oxoLCA-containing chow for a week (Fig. 4a) . 3-oxoLCA treatment led to a significant reduction in Th17 cell percentages among total CD4 + T cells isolated from the ilea of small intestines (Fig. 4b) . SFB colonization levels were comparable between control and 3-oxoLCA-treated groups, suggesting that the change in Th17 cell percentage was not due to a decrease in SFB in the 3-oxoLCA-10 treated mice (Fig. 4c) . In addition, Tac-B6 mice with pre-existing SFB had reduced levels of Th17 cell percentages when fed with 3-oxoLCA compared to control group fed with vehicle. On the other hand, 3-oxoLCA treatment did not affect Treg percentages (Extended Data Fig. 7a-c) .
Even under gut inflammatory conditions induced by an anti-CD3 injection, which is known to produce robust Th17 cell responses 18,41 , mice treated with 1%, but not with 0.3%, 3-oxoLCA 15 were found with reduced Th17 cell levels ( Fig. 4d and Extended Data Fig. 7d ). While isoalloLCA alone failed to affect Treg percentages (Extended Data Fig. 7e ), mice treated with anti-CD3 antibody and also fed with a mixture of 3-oxoLCA and isoalloLCA were found with increased Treg levels, compared to the vehicle-treated group (Fig. 4e) . Altogether, these data 
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Materials and Methods
Key Reagents
The white slurry was partially dissolved in CH2Cl2 (400 mL), transferred to a separatory funnel 5 containing a 5% aqueous solution of NaHSO3 (150 mL) and acidified to pH < 3 with 1 M HCl.
The layers were vigorously mixed, separated, and the aqueous layer was extracted with CH2Cl2 (3 x 25 mL). The combined organic layers were washed with saturated aqueous NaCl (50 mL), dried over Na2SO4 for >30 minutes, filtered and concentrated in vacuo. The resulting colorless to pale yellow oil forms a white solid over time as the AcOH is removed. The crude 1 H NMR 10 (CDCl3) shows only the desired product with AcOH; however, storage over about a day leads to a noticeable yellowing of the material that increases over time (presumably due to residual oxidant). The crude solid is purified by trituration with Et2O/hexanes. To break up any large chunks, Et2O (100 mL) and a stir bar are added to the crude solid and stirred. Hexane (100 mL) is then added while stirring, and then the contents were placed in an ice bath and mixing ceased. 15
Vacuum filtration with washing and vacuum drying afforded 3-oxoLCA as a white, crystalline solid (19.488 g, 52.028 mmol, 81.4% yield). The filtrate was concentrated and triturated in a similar manner (30 mL total of 1:1 Et2O/hexanes) to generate an additional portion of white crystalline solid (3.3836 g, 9.033 mmol, 14.1% yield). The combined mass of 3-oxoLCA was 
Flow Cytometry 10
Cells harvested from in vitro culture or in vivo mice experiments were stimulated with 50 ng/mL PMA (Phorbol 12-myristate 13-acetate) and 1 µM ionomycin in the presence of GolgiPlug for 4hr to determine cytokine expression. After stimulation, cells were stained with cell surface marker antibodies and LIVE/DEAD Fixable dye, Aqua, to exclude dead cells, fixed and permeabilized with a Foxp3/Transcription factor staining kit (eBioscience, #00552300), followed 15 by staining with cytokine-specific antibodies. All flow cytometry analyses were performed on an LSR II flow cytometer (BD) and data were analyzed with FlowJo software (TreeStar).
Cell Proliferation Assay
Naïve CD4 + T cells were labeled with 1 µM carboxyfluorescein succinimidyl ester (CFSE) and 20 cultured for 3 days prior to FACS analysis.
In Vitro Suppression Assay
A total of 2.5x10 4 freshly-purified naïve CD4 + CD25 -CD44 -CD62L high T cells (Tconv) from CD45.1 B6 mice were labeled with 1 µM CFSE, activated with soluble anti-CD3 (1 µg/mL) and 5x10 4 APCs in 96-well round-bottom plates for 3 days in the presence of tester cells (CD45.2).
The CFSE dilution of CD45.1 Tconv cells was assessed by flow cytometry.
5
Mammalian Luciferase Reporter Assay
Reporter assays were conducted as previously described 
RT-qPCR
Total RNA was isolated from cultured T cells using an RNeasy kit (Qiagen, #74134) and reverse 5 transcribed using a PrimeScript RT kit (Takara, #RR037A). Primers used for qPCR are listed in the primer table. All qPCRs were run on the Bio-Rad CFX real-time system using iTaq Universal SYBR Green Supermix (Bio-Rad, #1725124). β-actin was used as an internal control to normalize the data across different samples.
10
Metabolic Assays
In vitro differentiated cells were cultured in the presence of DMSO or isoalloLCA for 48 h.
Oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) were determined using a Seahorse XF96 Extracellular Flux Analyzer (Seahorse Bioscience) following protocols recommended by the manufacturer and according to the previously published method 
Mitochondrial Imaging and Quantification
Naïve CD4
+ T cells derived from PhaM excised mice 3 were cultured in the presence of DMSO or isoalloLCA for 2 days. Cells were then harvested and fixed with 4% paraformaldehyde for 20 mins, washed, immobilized on 2% agarose in PBS pads and covered with #1.5 coverslips.
Fluorescence images were acquired using a motorized Nikon Ti inverted microscope equipped 5 with a Yokogawa CSU-W1 spinning disk confocal head with a 50 m pinhole size, an Andor Zyla 4.2 plus sCMOS camera, Toptica iChrome MLE 4-color multi-laser engine (488, 515, 561 and 640 nm), SOLA 395 engine widefield illuminator, and Nikon motorized stage with a PI 250 µm piezo insert, using a Plan Apo 100x/1.45 DIC objective. Fluorescence imaging was performed using a Chroma quad multipass dichroic mirror and Chroma 525/36 nm bandpass 10 emission filter. The acquisition software was NIS Elements AR 5.02.
Chromatin immunoprecipitations
Chromatin immunoprecipitation (ChIP) assays were performed according to standard protocol.
Briefly, naïve CD4 + T cells were cultured for 48 h, and fixed for 10 min with 1% formaldehyde. 15
Then 0.125 M glycine was added to quench the formaldehyde. Cells were lysed, and chromatin was harvested and fragmented by sonication at a concentration of 10 7 cells/ChIP sample.
Chromatin was immunoprecipitated with 5 µg of ChIP or IgG control antibodies at 4 °C overnight and incubated with protein G magnetic beads (ThermoFisher, # 10001D) at 4 °C for 2 h, washed, and eluted in 150 µL elution buffer. Eluate DNA and input DNA were incubated at 20 65 °C to reverse the crosslinking. After digestion with proteinase K, DNA was purified with the QIAquick PCR purification kit (Qiagen, # 28104). The relative abundance of precipitated DNA fragments was analyzed by qPCR using SYBR Green Supermix (Bio-Rad, #1725124). Primer information is listed in the table.
Isolation of lamina propria lymphocytes
Gut tissues were harvested and treated with 1 mM DTT at room temperature for 10 min, and 5 5 mM EDTA at 37 °C for 20 min to remove epithelial cells, and dissociated in digestion buffer (RPMI, 1 mg/mL collagenase, 100 µg/mL DNase I, 5% FBS) with constant stirring at 37 °C for 30 min. Mononuclear cells were collected at the interface of a 40%/80% Percoll gradient (GE Healthcare). Cells were then analyzed by flow cytometry.
10
Animal experiments
For bile acid feeding experiments, the standard mouse diet in ground meal format (Picolab Diet, #5053) was evenly mixed with a measured amount of bile acid compounds and provided in glass feeder jars and replenished when necessary. Colonization of mice with SFB was done with fresh fecal samples, derived from il23r; rag2 double-knockout mice that are known to carry much 15 higher levels of SFB compared to conventional B6 mice. Fecal samples were homogenized in water using a 70 µm cell strainer and a 5 mL syringe plunger. Supernatant was introduced into mice using a 20G gavage needle at 250 µL/animal, approximately equal to the amount of 1/4 mouse fecal pellets.
20
Adoptive Transfer Colitis
CD45RB
hi adoptive transfer colitis was performed as described 4 . Briefly, isolated Representative FACS plots of T cells intracellularly stained for Foxp3 or IL17a. 
